Literature DB >> 21106750

Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.

Nicholas J Steers1, Jeffrey R Currier, Gustavo H Kijak, Robert C di Targiani, Ashima Saxena, Mary A Marovich, Jerome H Kim, Nelson L Michael, Carl R Alving, Mangala Rao.   

Abstract

Proteasomes are critical for the processing of antigens for presentation through the major histocompatibility complex (MHC) class I pathway. HIV-1 Gag protein is a component of several experimental HIV-1 vaccines. Therefore, understanding the processing of HIV-1 Gag protein and the resulting epitope repertoire is essential. Purified proteasomes from mature dendritic cells (DC) and activated CD4(+) T cells from the same volunteer were used to cleave full-length Gag-p24 protein, and the resulting peptide fragments were identified by mass spectrometry. Distinct proteasomal degradation patterns and peptide fragments were unique to either mature DC or activated CD4(+) T cells. Almost half of the peptides generated were cell type specific. Two additional differences were observed in the peptides identified from the two cell types. These were in the HLA-B35-Px epitope and the HLA-B27-KK10 epitope. These epitopes have been linked to HIV-1 disease progression. Our results suggest that the source of generation of precursor MHC class I epitopes may be a critical factor for the induction of relevant epitope-specific cytotoxic T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106750      PMCID: PMC3028885          DOI: 10.1128/JVI.01790-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

Review 1.  Mechanisms of MHC class I-restricted antigen processing and cross-presentation.

Authors:  Peter Cresswell; Anne L Ackerman; Alessandra Giodini; David R Peaper; Pamela A Wearsch
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

Review 2.  MHC class I alleles and their exploration of the antigen-processing machinery.

Authors:  Tom A M Groothuis; Alexander C Griekspoor; Joost J Neijssen; Carla A Herberts; Jacques J Neefjes
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

Review 3.  Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.

Authors:  Lianjun Shen; Kenneth L Rock
Journal:  Curr Opin Immunol       Date:  2005-12-02       Impact factor: 7.486

4.  Antigen processing of a short viral antigen by proteasomes.

Authors:  Daniel López; Olga Calero; Mercedes Jiménez; Margarita García-Calvo; Margarita Del Val
Journal:  J Biol Chem       Date:  2006-07-21       Impact factor: 5.157

5.  Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation.

Authors:  Jacques Chapiro; Stéphane Claverol; Fanny Piette; Wenbin Ma; Vincent Stroobant; Benoît Guillaume; Jean-Edouard Gairin; Sandra Morel; Odile Burlet-Schiltz; Bernard Monsarrat; Thierry Boon; Benoît J Van den Eynde
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

6.  Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation.

Authors:  Charles F Towne; Ian A York; Joost Neijssen; Margaret L Karow; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Jacques J Neefjes; Kenneth L Rock
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 7.  Modelling thymic HIV-1 Nef effects.

Authors:  Veronique Stove; Bruno Verhasselt
Journal:  Curr HIV Res       Date:  2006-01       Impact factor: 1.581

8.  HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.

Authors:  Emma L Turnbull; A Ross Lopes; Nicola A Jones; David Cornforth; Phillipa Newton; Diana Aldam; Pierre Pellegrino; Jo Turner; Ian Williams; Craig M Wilson; Paul A Goepfert; Mala K Maini; Persephone Borrow
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

9.  Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.

Authors:  Ian A York; Nidhi Bhutani; Sophia Zendzian; Alfred L Goldberg; Kenneth L Rock
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

10.  A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells.

Authors:  Anne L Ackerman; Alessandra Giodini; Peter Cresswell
Journal:  Immunity       Date:  2006-10-05       Impact factor: 43.474

View more
  11 in total

Review 1.  HIV and HLA class I: an evolving relationship.

Authors:  Philip J R Goulder; Bruce D Walker
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

2.  The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.

Authors:  Melissa A Cobleigh; Clinton Bradfield; Yuanjie Liu; Anand Mehta; Michael D Robek
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques.

Authors:  Suzanne E Queen; Brian M Mears; Kathleen M Kelly; Jamie L Dorsey; Zhaohao Liao; Jason B Dinoso; Lucio Gama; Robert J Adams; M Christine Zink; Janice E Clements; Stephen J Kent; Joseph L Mankowski
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

4.  Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.

Authors:  Marijana Rucevic; Georgio Kourjian; Julie Boucau; Renata Blatnik; Wilfredo Garcia Bertran; Matthew J Berberich; Bruce D Walker; Angelika B Riemer; Sylvie Le Gall
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 5.  Antigen processing and presentation in HIV infection.

Authors:  Julie Boucau; Sylvie Le Gall
Journal:  Mol Immunol       Date:  2018-04-07       Impact factor: 4.407

6.  Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.

Authors:  Jens Dinter; Ellen Duong; Nicole Y Lai; Matthew J Berberich; Georgio Kourjian; Edith Bracho-Sanchez; Duong Chu; Hang Su; Shao Chong Zhang; Sylvie Le Gall
Journal:  PLoS Pathog       Date:  2015-03-17       Impact factor: 6.823

7.  HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses.

Authors:  Nicholas J Steers; Silvia Ratto-Kim; Mark S de Souza; Jeffrey R Currier; Jerome H Kim; Nelson L Michael; Carl R Alving; Mangala Rao
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

8.  Computational and experimental validation of B and T-cell epitopes of the in vivo immune response to a novel malarial antigen.

Authors:  Elke S Bergmann-Leitner; Sidhartha Chaudhury; Nicholas J Steers; Mark Sabato; Vito Delvecchio; Anders S Wallqvist; Christian F Ockenhouse; Evelina Angov
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

9.  Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.

Authors:  Julia Schmidt; Astrid K N Iversen; Stefan Tenzer; Emma Gostick; David A Price; Volker Lohmann; Ute Distler; Paul Bowness; Hansjörg Schild; Hubert E Blum; Paul Klenerman; Christoph Neumann-Haefelin; Robert Thimme
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

Review 10.  Mechanisms of HIV protein degradation into epitopes: implications for vaccine design.

Authors:  Marijana Rucevic; Julie Boucau; Jens Dinter; Georgio Kourjian; Sylvie Le Gall
Journal:  Viruses       Date:  2014-08-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.